Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Keynote Speakers from Medtronic and Ketryx Corporation Taking the Stage at BIOMEDevice Silicon Valley

BIOMEDevice Silicon Valley, the must-attend regional show connecting engineers and cutting-edge medtech companies, today announces registration is now live for November. The event also shares its keynote speaker agenda, alongside notable attending companies expected to connect and trade at the technology-driven forum.

BIOMEDevice Silicon Valley running November 29-30 at the Santa Clara Convention Center, will be packed full of hundreds of industry-leading suppliers. Notable exhibitors confirmed include Accumold, Canon Medical Systems USA, HIWIN Corporation, KNF Neuberger, Nelson Labs LLC, Qosina, Velentium, among others.

"Held in the heart of technological innovation, the Silicon Valley event connects decision-making buyers and sellers in real time to demonstrate and discuss emerging trends and evolving practices as new tech propels the advancement of the medical device industry forward," said Adrienne Zepeda, Group Event Director. "It is critical to be in-the-know now more than ever as regulations change and new needs unfold, the sessions and exhibitors at BIOMEDevice Silicon Valley are designed to experience how this impacts the field."

BIOMEDevice Silicon Valley also offers the Smart Event platform, which extends the BIOMEDevice experience, allowing guests more time to research brands and network with attending leaders in advance of the show, remotely, or post-conference. Thousands of attending buyers and industry professionals include Abbott Laboratories, Johnson & Johnson, Medtronic, Stryker, UCSF, US Army Medical Department and more.

The opening keynote will feature Erez Kaminski, CEO & Founder of Ketryx Corporation, focusing on Medical AI and ML as well as how best to build cloud-based systems alongside changing regulations. Kaminski will discuss challenges of safety-critical software development for startups, overlooked development risks, and best practices utilizing FDA patient protection in real-life examples such as medical and nuclear software.

Following on the second day, Yarmela Pavlovic, VP of Global Regulatory Strategy & Policy of Medtronic, will review the transformation of cybersecurity and how to best understand the landscape of evolving FDA expectations. As healthcare increasingly relies on connected and digital solutions to provide and improve outcomes in patient care, Pavlovic will explore the evolving FDA policy seeking to improve the resilience of medical devices against cybersecurity threats.

Registration for BIOMEDevice Silicon Valley is now open and available through www.biomedevicesiliconvalley.com/en/home. Secure your pass to access exclusive content available today through the online Smart Event platform, connect with buyers and explore new partnerships in advance of the show.

About Informa Markets Engineering:

Informa Markets' Engineering portfolio is the leading B2B event producer, publisher, and digital media business for the world's $3 trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3 million name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them thrive 365 days of the year. For more information, visit www.informamarkets.com, and keep up to date with the latest Informa Markets engineering news on Twitter, Facebook and LinkedIn.

About Informa Markets:

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio comprises more than 550 international B2B events and brands in markets including Engineering, Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world's leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, visit www.informamarkets.com.

These press releases may also interest you

at 16:30
In response to severe weather in Texas, Blue Cross Blue Shield of Massachusetts (Blue Cross) is expediting access to care for members who may be affected.  ...

at 16:10
Gilead Sciences, Inc. announced today that its executives will be speaking at the following investor conferences: SVB Securities Global Biopharma Conference on Tuesday, February 14 at 11:20 AM Eastern Time Cowen Annual Health Care Conference on...

at 16:10
Horizon Therapeutics plc : RECOMMENDED CASH OFFER for HORIZON THERAPEUTICS PLC by Pillartree Limited, a newly formed private limited company wholly owned by Amgen Inc. to be implemented by way of a scheme of arrangement under Chapter 1 of Part...

at 16:10
Junior R. King, DPM, is being recognized by Continental Who's Who as a Distinguished Healthcare Provider for his contributions to the medical field. Dr. King graduated with a medical degree from the Temple University School of Podiatric Medicine, a...

at 16:05
Bright Minds Biosciences Inc. ("Bright Minds" or the "Company") announces that it has received a notification letter (the "Notification Letter") from the Nasdaq Stock Market LLC ("NASDAQ") dated January 26, 2023, notifying the Company that due to...

at 16:05
Inhibikase Therapeutics, Inc. ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases...

News published on 25 october 2022 at 12:25 and distributed by: